Trial Profile
Examination of the efficacy and safety of Doripenem for hospital-aquired pneumonia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jan 2012
Price :
$35
*
At a glance
- Drugs Doripenem (Primary)
- Indications Bacterial infections; Nosocomial pneumonia
- Focus Therapeutic Use
- 09 Jan 2012 New trial record